Griseofulvin Remedica (Griseofulvin)

Griseofulvin Remedica is prescribed for the treatment of dermatophyte infections that affect the skin, hair, and nails. It is commonly used when topical agents are insufficient or when the infection involves extensive areas.

• Tinea corporis (ringworm of the body)
• Tinea capitis (scalp ringworm)
• Tinea pedis (athlete's foot)
• Tinea unguium (fungal nail infection)
• Other superficial dermatophyte infections confirmed by laboratory testing

Side effects of Griseofulvin Remedica vary in frequency and severity. Patients should be aware of both common and less frequent serious reactions.

Common

• Headache
• Nausea or vomiting
• Diarrhea
• Abdominal discomfort
• Skin rash or itching
• Elevated liver enzymes

Serious

• Severe allergic reaction (anaphylaxis, angioedema)
• Hepatotoxicity (jaundice, hepatitis)
• Blood dyscrasias (e.g., leukopenia, thrombocytopenia)
• Photosensitivity leading to severe sunburn

Before starting Griseofulvin Remedica, certain precautions should be considered to minimize risks.

• Assess liver function, as the drug is metabolized hepatically.
• Review patient history for hematologic disorders or immune suppression.
• Counsel patients on avoiding excessive sunlight due to photosensitivity.
• Use caution in pregnant or breastfeeding women; safety data are limited.
• Monitor for signs of rash or allergic reaction, especially during the first weeks of therapy.
• Adjust dosage in patients with renal impairment if required by clinical judgment.

Griseofulvin Remedica can interact with other medicines, affecting its efficacy or safety. Interactions are grouped by the level of concern.

Avoid

• CYP3A4 inducers such as rifampin, carbamazepine, and phenytoin, which may reduce griseofulvin levels.
• Live vaccines, because immunosuppression could diminish vaccine effectiveness.

Use with caution

• Oral contraceptives, as griseofulvin may decrease their effectiveness.
• Anticoagulants (e.g., warfarin), which may have altered plasma concentrations.
• Other hepatotoxic drugs, increasing risk of liver injury.
• Immunosuppressants, potentially enhancing infection risk.